A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy
Clinical trial NCT01695135 · COMPLETED
Trial details
- NCT number
- NCT01695135
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-09
- Primary completion
- 2014-06-20
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.